BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 10072686)

  • 1. Substrate specificity and stereoselectivity of rat brain microsomal anandamide amidohydrolase.
    Lang W; Qin C; Lin S; Khanolkar AD; Goutopoulos A; Fan P; Abouzid K; Meng Z; Biegel D; Makriyannis A
    J Med Chem; 1999 Mar; 42(5):896-902. PubMed ID: 10072686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel analogues of arachidonylethanolamide (anandamide): affinities for the CB1 and CB2 cannabinoid receptors and metabolic stability.
    Lin S; Khanolkar AD; Fan P; Goutopoulos A; Qin C; Papahadjis D; Makriyannis A
    J Med Chem; 1998 Dec; 41(27):5353-61. PubMed ID: 9876105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A hydrolase enzyme inactivating endogenous ligands for cannabinoid receptors.
    Ueda N; Goparaju SK; Katayama K; Kurahashi Y; Suzuki H; Yamamoto S
    J Med Invest; 1998 Aug; 45(1-4):27-36. PubMed ID: 9864962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the kinetics and distribution of N-arachidonylethanolamine (anandamide) hydrolysis by rat brain.
    Hillard CJ; Wilkison DM; Edgemond WS; Campbell WB
    Biochim Biophys Acta; 1995 Aug; 1257(3):249-56. PubMed ID: 7647100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anandamide amidohydrolase activity in rat brain microsomes. Identification and partial characterization.
    Desarnaud F; Cadas H; Piomelli D
    J Biol Chem; 1995 Mar; 270(11):6030-5. PubMed ID: 7890734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial purification and characterization of the porcine brain enzyme hydrolyzing and synthesizing anandamide.
    Ueda N; Kurahashi Y; Yamamoto S; Tokunaga T
    J Biol Chem; 1995 Oct; 270(40):23823-7. PubMed ID: 7559559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploration of biologically relevant conformations of anandamide, 2-arachidonylglycerol, and their analogues using conformational memories.
    Barnett-Norris J; Guarnieri F; Hurst DP; Reggio PH
    J Med Chem; 1998 Nov; 41(24):4861-72. PubMed ID: 9822555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationships of anandamide, an endogenous cannabinoid ligand.
    Khanolkar AD; Makriyannis A
    Life Sci; 1999; 65(6-7):607-16. PubMed ID: 10462061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversible hydrolysis and synthesis of anandamide demonstrated by recombinant rat fatty-acid amide hydrolase.
    Kurahashi Y; Ueda N; Suzuki H; Suzuki M; Yamamoto S
    Biochem Biophys Res Commun; 1997 Aug; 237(3):512-5. PubMed ID: 9299394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of anandamide amidase activity using ultraviolet-active amine derivatives and reverse-phase high-performance liquid chromatography.
    Qin C; Lin S; Lang W; Goutopoulos A; Pavlopoulos S; Mauri F; Makriyannis A
    Anal Biochem; 1998 Jul; 261(1):8-15. PubMed ID: 9683506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatty acid sulfonyl fluorides inhibit anandamide metabolism and bind to the cannabinoid receptor.
    Deutsch DG; Lin S; Hill WA; Morse KL; Salehani D; Arreaza G; Omeir RL; Makriyannis A
    Biochem Biophys Res Commun; 1997 Feb; 231(1):217-21. PubMed ID: 9070252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural and synthetic endocannabinoids and their structure-activity relationships.
    Palmer SL; Khanolkar AD; Makriyannis A
    Curr Pharm Des; 2000 Sep; 6(13):1381-97. PubMed ID: 10903399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of endocannabinoid inactivation: biochemistry and pharmacology.
    Giuffrida A; Beltramo M; Piomelli D
    J Pharmacol Exp Ther; 2001 Jul; 298(1):7-14. PubMed ID: 11408519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anandamide amidohydrolase reacting with 2-arachidonoylglycerol, another cannabinoid receptor ligand.
    Goparaju SK; Ueda N; Yamaguchi H; Yamamoto S
    FEBS Lett; 1998 Jan; 422(1):69-73. PubMed ID: 9475172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An acid amidase hydrolyzing anandamide as an endogenous ligand for cannabinoid receptors.
    Ueda N; Yamanaka K; Terasawa Y; Yamamoto S
    FEBS Lett; 1999 Jul; 454(3):267-70. PubMed ID: 10431820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-acyl-dopamines: novel synthetic CB(1) cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo.
    Bisogno T; Melck D; Bobrov MYu ; Gretskaya NM; Bezuglov VV; De Petrocellis L; Di Marzo V
    Biochem J; 2000 Nov; 351 Pt 3(Pt 3):817-24. PubMed ID: 11042139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unsaturated long-chain N-acyl-vanillyl-amides (N-AVAMs): vanilloid receptor ligands that inhibit anandamide-facilitated transport and bind to CB1 cannabinoid receptors.
    Melck D; Bisogno T; De Petrocellis L; Chuang H; Julius D; Bifulco M; Di Marzo V
    Biochem Biophys Res Commun; 1999 Aug; 262(1):275-84. PubMed ID: 10448105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzymatic synthesis of anandamide, an endogenous ligand for the cannabinoid receptor, by brain membranes.
    Devane WA; Axelrod J
    Proc Natl Acad Sci U S A; 1994 Jul; 91(14):6698-701. PubMed ID: 8022836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformational requirements for endocannabinoid interaction with the cannabinoid receptors, the anandamide transporter and fatty acid amidohydrolase.
    Reggio PH; Traore H
    Chem Phys Lipids; 2000 Nov; 108(1-2):15-35. PubMed ID: 11106780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereochemical selectivity of methanandamides for the CB1 and CB2 cannabinoid receptors and their metabolic stability.
    Goutopoulos A; Fan P; Khanolkar AD; Xie XQ; Lin S; Makriyannis A
    Bioorg Med Chem; 2001 Jul; 9(7):1673-84. PubMed ID: 11425567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.